Market Research Reports, Inc.

U.S. Orthopedic Biomaterials Market – 2015, New Report Launched

The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone.

Orthopedic biomaterial products compete with products that are more established and less expensive. Thus, clinical evidence is often an important deciding factor for orthopedic biomaterials over conventional forms of therapy especially in regards to reimbursement. However, the promise seen in some products such as bone marrow concentrate generates growth despite a lack of clinical evidence and reimbursement.

The U.S. orthopedic biomaterials market includes bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid viscosupplementation, cartilage repair and machined bone allografts.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Indepth Procedure Volumes
  • Market Overview by Segment
  • Trend Analysis by Segment
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Segments Covered:

  • U.S. Orthopedic Biomaterials Procedures
  • Orthopedic Bone Graft Substitute Market
  • Orthopedic Growth Factor Market
  • Orthopedic Stem Cell Market
  • Orthopedic Cell Therapy Market
  • Orthopedic Hyaluronic Acid Viscosupplementation Market
  • Orthopedic Cartilage Repair Market
  • Spinal Machined Bone Allograft Market

Report Highlights:

  • A wide range of devices/treatments covered in the report focused around regenerative and resorbable orthopedic options
  • Complementary products such as PRP (provides growth factor) and BMC (provides stem cells) used in conjunction with bone graft substitutes. Allows the graft to compete with growth factor and stem cell bone grafts
  • Highlights trend towards demineralized bone matrices and synthetics
  • Competitive analysis broken down for each type: allograft, DBM and synthetics
  • A wide range of devices/treatments covered in the report focused around regenerative and resorbable orthopedic options
  • Cartilage repair market includes two new segments: juvenile particulated allograft (Zimmer’s DeNovo) and microfracture adjunct (Arthrex’s BioCartilage)

Spanning over 288 pages “U.S. Orthopedic Biomaterials Market – 2015” report Covering Executive Summary, Research Methodology, U.S. Orthopedic Biomaterials Market Overview, Procedure Numbers, Orthopedic Bone Graft Substitute Market, Orthopedic Growth Factor Market, Orthopedic Stem Cell Market, Orthopedic Cell Therapy Market, Orthopedic Hyaluronic Acid Viscosupplementation Market, Orthopedic Cartilage Repair Market, Spinal Machined Bone Allograft Market. This report Covered 22 Companies – Aastrom, Allosource, Anika Therapeutics, Artrhex, Baxter, Biomet, Bioventus, DePuy Synthes, Exactech, Ferring Pharmaceuticals, Fidia Pharmaceuticals, Genzyme, Harvest, Integra LifeSciences, MTF, Medtronic, NuVasive, Orthofix, RTI Surgical, Stryker, Wright Medical, Zimmer.

Know more about this report at –

Find all Biotechnology Reports at:

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.